{"transactions":[{"id":4634315,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":10585,"kind":"person","name":"Quaggin Susan E","position":1,"cik":"0001997505","reported_name":"Quaggin Susan E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2026-10-03T01:00:11.000Z","date":"2026-09-30","kind":"grant","planned":false,"acquired":true,"shares":59,"price":261.59,"value":15433.81,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to an unfunded book account in the director's name are distributed over a period equal to the director's years of board service, generally commencing at the later of age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to an unfunded book account in the director's name are distributed over a period equal to the director's years of board service, generally commencing at the later of age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":918,"derivative":{"exercise_price":261.59,"underlying":"Common Stock","underlying_shares":59},"source":{"system":"sec-edgar","filing":"0001997505-26-000010","document":"form4-10022026_051005.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1997505/000199750526000010/form4-10022026_051005.xml","form_type":"4"}},{"id":7055,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":10585,"kind":"person","name":"Quaggin Susan E","position":1,"cik":"0001997505","reported_name":"Quaggin Susan E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2026-07-02T21:00:12.000Z","date":"2026-06-30","kind":"grant","planned":false,"acquired":true,"shares":62,"price":251.64,"value":15601.68,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to an unfunded book account in the director's name are distributed over a period equal to the director's years of board service, generally commencing at the later of age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to an unfunded book account in the director's name are distributed over a period equal to the director's years of board service, generally commencing at the later of age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":853,"derivative":{"exercise_price":251.64,"underlying":"Common Stock","underlying_shares":62},"source":{"system":"sec-edgar","filing":"0001997505-26-000008","document":"form4-07022026_050702.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1997505/000199750526000008/form4-07022026_050702.xml","form_type":"4"}},{"id":9906,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":10585,"kind":"person","name":"Quaggin Susan E","position":1,"cik":"0001997505","reported_name":"Quaggin Susan E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.01 par value","published_at":"2026-05-12T21:00:23.000Z","date":"2026-05-08","kind":"grant","planned":false,"acquired":true,"shares":1118,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These are restricted stock units awarded under the AbbVie Amended and Restated 2013 Incentive Stock Program (the \"Program\"). They will be paid, on a one-to-one basis, in shares of AbbVie common stock on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program)."}],"balance_after":3643,"source":{"system":"sec-edgar","filing":"0001997505-26-000006","document":"form4-05122026_050515.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1997505/000199750526000006/form4-05122026_050515.xml","form_type":"4"}},{"id":10988,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":10585,"kind":"person","name":"Quaggin Susan E","position":1,"cik":"0001997505","reported_name":"Quaggin Susan E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2026-04-02T21:00:15.000Z","date":"2026-03-31","kind":"grant","planned":false,"acquired":true,"shares":71,"price":217.49,"value":15441.79,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":784,"derivative":{"exercise_price":217.49,"underlying":"Common Stock","underlying_shares":71},"source":{"system":"sec-edgar","filing":"0001997505-26-000004","document":"form4-04022026_050411.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1997505/000199750526000004/form4-04022026_050411.xml","form_type":"4"}},{"id":15616,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":10585,"kind":"person","name":"Quaggin Susan E","position":1,"cik":"0001997505","reported_name":"Quaggin Susan E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2026-01-05T22:00:15.000Z","date":"2025-12-31","kind":"grant","planned":false,"acquired":true,"shares":68,"price":228.49,"value":15537.32,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":707,"derivative":{"exercise_price":228.49,"underlying":"Common Stock","underlying_shares":68},"source":{"system":"sec-edgar","filing":"0001997505-26-000002","document":"form4-01052026_050108.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1997505/000199750526000002/form4-01052026_050108.xml","form_type":"4"}},{"id":18842,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":10585,"kind":"person","name":"Quaggin Susan E","position":1,"cik":"0001997505","reported_name":"Quaggin Susan E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2025-10-02T21:00:41.000Z","date":"2025-09-30","kind":"grant","planned":false,"acquired":true,"shares":67,"price":231.54,"value":15513.18,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":634,"derivative":{"exercise_price":231.54,"underlying":"Common Stock","underlying_shares":67},"source":{"system":"sec-edgar","filing":"0001997505-25-000005","document":"form4-10022025_051001.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1997505/000199750525000005/form4-10022025_051001.xml","form_type":"4"}},{"id":22044,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":10585,"kind":"person","name":"Quaggin Susan E","position":1,"cik":"0001997505","reported_name":"Quaggin Susan E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2025-07-02T21:00:09.000Z","date":"2025-06-30","kind":"grant","planned":false,"acquired":true,"shares":81,"price":185.62,"value":15035.22,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":562,"derivative":{"exercise_price":185.62,"underlying":"Common Stock","underlying_shares":81},"source":{"system":"sec-edgar","filing":"0001415889-25-019105","document":"form4-07022025_050701.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1997505/000141588925019105/form4-07022025_050701.xml","form_type":"4"}},{"id":24071,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":10585,"kind":"person","name":"Quaggin Susan E","position":1,"cik":"0001997505","reported_name":"Quaggin Susan E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.01 par value","published_at":"2025-05-13T21:05:19.000Z","date":"2025-05-09","kind":"grant","planned":false,"acquired":true,"shares":1203,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These are restricted stock units awarded under the AbbVie Amended and Restated 2013 Incentive Stock Program (the \"Program\"). They will be paid, on a one-to-one basis, in shares of AbbVie common stock on the earlier of the date of the director's separation from\nservice, death, or the occurrence of a change in control (as defined in the Program)."}],"balance_after":2525,"source":{"system":"sec-edgar","filing":"0001415889-25-012799","document":"form4-05132025_050515.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1997505/000141588925012799/form4-05132025_050515.xml","form_type":"4"}},{"id":25228,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":10585,"kind":"person","name":"Quaggin Susan E","position":1,"cik":"0001997505","reported_name":"Quaggin Susan E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2025-04-02T21:00:10.000Z","date":"2025-03-31","kind":"grant","planned":false,"acquired":true,"shares":71,"price":209.52,"value":14875.92,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":476,"derivative":{"exercise_price":209.52,"underlying":"Common Stock","underlying_shares":71},"source":{"system":"sec-edgar","filing":"0001415889-25-009689","document":"form4-04022025_050407.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1997505/000141588925009689/form4-04022025_050407.xml","form_type":"4"}},{"id":30894,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":10585,"kind":"person","name":"Quaggin Susan E","position":1,"cik":"0001997505","reported_name":"Quaggin Susan E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2025-01-03T22:00:12.000Z","date":"2024-12-31","kind":"grant","planned":false,"acquired":true,"shares":84,"price":177.7,"value":14926.8,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":401,"derivative":{"exercise_price":177.7,"underlying":"Common Stock","underlying_shares":84},"source":{"system":"sec-edgar","filing":"0001415889-25-000519","document":"form4-01032025_050103.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1997505/000141588925000519/form4-01032025_050103.xml","form_type":"4"}},{"id":35044,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":10585,"kind":"person","name":"Quaggin Susan E","position":1,"cik":"0001997505","reported_name":"Quaggin Susan E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2024-10-02T21:00:11.000Z","date":"2024-09-30","kind":"grant","planned":false,"acquired":true,"shares":75,"price":197.48,"value":14811.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":314,"derivative":{"exercise_price":197.48,"underlying":"Common Stock","underlying_shares":75},"source":{"system":"sec-edgar","filing":"0001415889-24-024450","document":"form4-10022024_051002.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1997505/000141588924024450/form4-10022024_051002.xml","form_type":"4"}},{"id":38649,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":10585,"kind":"person","name":"Quaggin Susan E","position":1,"cik":"0001997505","reported_name":"Quaggin Susan E","relationship":{"director":true}}],"security":"Stock Equivalent Units","published_at":"2024-07-02T20:20:34.000Z","date":"2024-06-30","kind":"grant","planned":false,"acquired":true,"shares":87,"price":171.52,"value":14922.24,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":236,"derivative":{"exercise_price":171.52,"underlying":"Common Stock","underlying_shares":87},"source":{"system":"sec-edgar","filing":"0000897069-24-001475","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1997505/000089706924001475/form4.xml","form_type":"4"}},{"id":41197,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":10585,"kind":"person","name":"Quaggin Susan E","position":1,"cik":"0001997505","reported_name":"Quaggin Susan E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.01 par value","published_at":"2024-05-07T22:31:46.000Z","date":"2024-05-03","kind":"grant","planned":false,"acquired":true,"shares":1322,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These are restricted stock units awarded under the AbbVie Amended and Restated 2013 Incentive Stock Program (the \"Program\"). They will be paid, on a one-to-one basis, in shares of AbbVie common stock on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program)."}],"balance_after":1322,"source":{"system":"sec-edgar","filing":"0001415889-24-012530","document":"form4-05072024_100540.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1997505/000141588924012530/form4-05072024_100540.xml","form_type":"4"}},{"id":42131,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":10585,"kind":"person","name":"Quaggin Susan E","position":1,"cik":"0001997505","reported_name":"Quaggin Susan E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2024-04-02T21:00:37.000Z","date":"2024-03-31","kind":"grant","planned":false,"acquired":true,"shares":82,"price":182.1,"value":14932.2,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":147,"derivative":{"exercise_price":182.1,"underlying":"Common Stock","underlying_shares":82},"source":{"system":"sec-edgar","filing":"0001415889-24-009800","document":"form4-04022024_050401.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1997505/000141588924009800/form4-04022024_050401.xml","form_type":"4"}},{"id":48930,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":10585,"kind":"person","name":"Quaggin Susan E","position":1,"cik":"0001997505","reported_name":"Quaggin Susan E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2024-01-03T22:17:30.000Z","date":"2023-12-31","kind":"grant","planned":false,"acquired":true,"shares":64,"price":154.97,"value":9918.08,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock."}],"balance_after":64,"derivative":{"exercise_price":154.97,"underlying":"Common Stock","underlying_shares":64},"source":{"system":"sec-edgar","filing":"0001415889-24-000345","document":"form4-01032024_100158.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1997505/000141588924000345/form4-01032024_100158.xml","form_type":"4"}}]}